A comprehensive map of the mTOR signaling network

Etienne Caron1, Samik Ghosh, Yukiko Matsuoka

  • 1Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada.

Molecular Systems Biology
|December 24, 2010
PubMed

Insights

This study presents a detailed map of the mammalian target of rapamycin (mTOR) signaling network, crucial for understanding cell growth and cancer. This resource aids in discovering new anticancer therapies by analyzing mTOR

Area of Science:

  • Systems Biology
  • Molecular Biology
  • Oncology

Background:

  • The mammalian target of rapamycin (mTOR) pathway is a critical regulator of cell growth, proliferation, and metabolism.
  • Dysregulation of mTOR signaling is a hallmark of many cancers, making it a key target for anticancer drug development.
  • A comprehensive understanding of the intricate network of mTOR signaling is essential for effective therapeutic strategies.

Purpose of the Study:

  • To create a comprehensive computational map of the mammalian target of rapamycin (mTOR) signaling network.
  • To facilitate systems-level analysis of mTOR signaling dynamics and regulatory mechanisms.
  • To identify novel therapeutic targets and strategies for drug-based cancer therapy by examining mTOR feedback and crosstalk.

Main Methods:

  • Utilized CellDesigner software for the graphical and computational modeling of the mTOR signaling network.
  • Developed a detailed map comprising 964 species and 777 reactions, adhering to Systems Biology Markup Language (SBML) and Systems Biology Graphical Notation (SBGN) standards.
  • Integrated the map into the Payao platform for community-wide access and collaborative refinement.

Main Results:

  • A comprehensive and standardized map of the mTOR signaling network has been successfully constructed.
  • The map visually represents 964 molecular species and 777 biochemical reactions within the mTOR pathway.
  • The model captures complex feedback and crosstalk regulations inherent to the mTOR network.

Conclusions:

  • The developed mTOR network map serves as a valuable tool for systems-level investigation of cellular signaling.
  • This resource enhances the understanding of mTOR's role in cancer and its regulation by feedback and crosstalk.
  • Facilitates the discovery of novel regulatory processes and innovative therapeutic strategies for cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...